We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,085 results
  1. The influence of cyclooxygenase inhibitors on kynurenic acid production in rat kidney: a novel path for kidney protection?

    Background

    Kidney diseases have become a global health problem, affecting about 15% of adults and being often under-recognized. Immunological system...

    Izabela Zakrocka, Wojciech Załuska in Pharmacological Reports
    Article Open access 14 February 2023
  2. Protective effects of long-term nitrate administration against ovariectomy-induced kidney dysfunction in rats

    Background

    Menopause is associated with higher risks of chronic kidney disease. We determined the effect of nitrate on ovariectomy-induced kidney...

    Nasibeh Yousefzadeh, Sajad Jeddi, ... Asghar Ghasemi in Pharmacological Reports
    Article 01 June 2023
  3. Reno-protective effect of protocatechuic acid is independent of sex-related differences in murine model of UUO-induced kidney injury

    Background

    Obstructive nephropathy is a condition often caused by urinary tract obstruction either anatomical (e.g., tumors), mechanical (e.g.,...

    Karim M. Saad, Évila Lopes Salles, ... Ahmed A. Elmarakby in Pharmacological Reports
    Article 12 January 2024
  4. Sodium–glucose cotransporter inhibitors and kidney fibrosis: review of the current evidence and related mechanisms

    Sodium–glucose cotransporter inhibitors (SGLT2i) are a new class of anti-diabetic drugs that have beneficial cardiovascular and renal effects. These...

    Baris Afsar, Rengin Elsurer Afsar in Pharmacological Reports
    Article 19 December 2022
  5. Pten knockout affects drug resistance differently in melanoma and kidney cancer

    Background

    PTEN is a tumor suppressor that is often mutated and nonfunctional in many types of cancer. The high heterogeneity of PTEN function between...

    Klaudia Brodaczewska, Aleksandra Majewska, ... Claudine Kieda in Pharmacological Reports
    Article Open access 06 September 2023
  6. Desidustat in anaemia in patients with chronic kidney disease: a profile of its use

    Desidustat (Oxemia ), a hypoxia-inducible factor prolyl hydroxylase inhibitor, is a promising new oral alternative to injectable...

    Tina Nie, Yahiya Y. Syed in Drugs & Therapy Perspectives
    Article 13 July 2023
  7. 2-Mercaptoethanol protects against DNA double-strand breaks after kidney ischemia and reperfusion injury through GPX4 upregulation

    Background

    Kidney ischemia reperfusion injury (IRI) is characterized by tubular cell death. DNA double-strand breaks is one of the major sources of...

    Daeun Moon, Babu J. Padanilam, ... **u Kim in Pharmacological Reports
    Article 22 August 2022
  8. Kynurenine pathway in kidney diseases

    Kidney diseases have become one of the most common health care problems. Due to a growing number of advanced aged patients with concomitant disorders...

    Izabela Zakrocka, Wojciech Załuska in Pharmacological Reports
    Article Open access 06 October 2021
  9. Prevalence, types and disclosure of complementary and alternative medicine (CAM) use among chronic kidney disease (CKD) patients in Saudi Arabia

    Introduction

    Despite the paucity of scientific evidence, CAM is widely used for the prevention and treatment of illness among patients with chronic...

    Ghada Ben Salah, Maryam Farooqui, ... Muhammad Kamran Rasheed in Journal of Pharmaceutical Policy and Practice
    Article Open access 14 July 2023
  10. Astaxanthin- Enriched Fraction from the Microalga Haematococcus pluvialis Mitigates Kidney Injury via Modulation of Nrf2/Keap1 and MAPK/ERK Pathways in Rats

    Acute kidney injury is a complication of using gentamicin in high doses and is associated with severe morbidity and mortality. Astaxanthin, the red...

    Farouk K. El-Baz, Sami I. Ali, ... Rania Elgohary in Revista Brasileira de Farmacognosia
    Article Open access 16 February 2023
  11. Difelikefalin in pruritus associated with chronic kidney disease: a profile of its use

    Difelikefalin (Kapruvia ® ; Korsuva™), a novel peripheral kappa opioid receptor (KOR) agonist, is a promising emerging treatment for moderate-to-severe...

    Yvette N. Lamb in Drugs & Therapy Perspectives
    Article Open access 14 September 2022
  12. Knowledge, attitude and perceptions of pharmacists regarding renal dose adjustment among chronic kidney disease patients in Pakistan

    Background

    Chronic kidney disease (CKD) poses a significant public health challenge. CKD patients have compromised renal function, which not only...

    Roheena Zafar, Inayat Ur Rehman, ... Tahir Mehmood Khan in Journal of Pharmaceutical Policy and Practice
    Article Open access 19 September 2023
  13. Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET® Medical Information Database Network in Japan

    An association between kidney disease and direct-acting antivirals against hepatitis C (DAAs) has been suggested, however the warning on the package...

    Tomoaki Hasegawa, Sono Sawada, ... Yoshiaki Uyama in Therapeutic Innovation & Regulatory Science
    Article Open access 18 April 2022
  14. Improve medication adherence in older adults with chronic kidney disease by identifying and addressing underlying factors

    Medication adherence is crucial to slowing disease progression and death in older adults with chronic kidney disease (CKD). However, as much as half...

    Esther S. Kim, Connie Kang in Drugs & Therapy Perspectives
    Article 15 September 2021
  15. How Kidney Function Affects Drug Pharmacokinetics

    The kidneyKidney is the most important organ for excretingPharmacokinetics (PK) drugs, including drugs metabolised by the liver, and impaired...
    Chapter 2020
  16. Activation of β2 adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases

    Beta 2 adrenergic receptor (β 2 -AR)-agonists, widely used as bronchodilators, have demonstrated wide-spectrum anti-inflammatory properties in both...

    Debra Dorotea, Hunjoo Ha in Archives of Pharmacal Research
    Article 05 November 2020
  17. Beneficial Effects of Punica granatum L. Juice and Gallic Acid Against Kidney Oxidative Damage Caused by Sodium Fluoride

    The present work was undertaken to study the effect of sodium fluoride (NaF) exposure on renal oxidative stress status in rats and to evaluate the...

    Asma Bouasla, Choukri Barour, ... Mahfoud Messarah in Pharmaceutical Chemistry Journal
    Article 01 December 2021
  18. Chronic Kidney Disease and End Stage Renal Disease

    This chapter will describe the practice End stage renal disease (ESRD) essentials that are considered standard of care, common conditions and their...
    Dan Martinusen, Judith G. Marin, ... Wynnie Lau in Renal Medicine and Clinical Pharmacy
    Chapter 2020
  19. Acute Kidney Injury: Pre-renal, Intra-renal and Post-renal

    Acute kidney injury (AKI) occurs when there is an acute fallAcute Kidney Injury (AKI) Pre-renal Intra-renal Post-renal in glomerular filtration...
    Christine Sluman, Pooja Mehta Gudka, Kathryn McCormick in Renal Medicine and Clinical Pharmacy
    Chapter 2020
Did you find what you were looking for? Share feedback.